nodes	percent_of_prediction	percent_of_DWPC	metapath
Azelastine—CYP2A6—stomach cancer	0.381	1	CbGaD
Azelastine—ABCB1—Mitomycin—stomach cancer	0.0618	0.175	CbGbCtD
Azelastine—CYP2A6—Fluorouracil—stomach cancer	0.0456	0.129	CbGbCtD
Azelastine—CYP2B6—Irinotecan—stomach cancer	0.0309	0.0874	CbGbCtD
Azelastine—CYP2C9—Capecitabine—stomach cancer	0.0264	0.0748	CbGbCtD
Azelastine—CYP3A5—Irinotecan—stomach cancer	0.0243	0.0689	CbGbCtD
Azelastine—CYP2C8—Fluorouracil—stomach cancer	0.0225	0.0635	CbGbCtD
Azelastine—CYP3A5—Docetaxel—stomach cancer	0.0178	0.0505	CbGbCtD
Azelastine—CYP1A2—Fluorouracil—stomach cancer	0.0174	0.0492	CbGbCtD
Azelastine—CYP2B6—Doxorubicin—stomach cancer	0.0169	0.0478	CbGbCtD
Azelastine—ABCB1—Irinotecan—stomach cancer	0.0158	0.0448	CbGbCtD
Azelastine—CYP2C9—Fluorouracil—stomach cancer	0.0157	0.0443	CbGbCtD
Azelastine—ABCB1—Docetaxel—stomach cancer	0.0116	0.0328	CbGbCtD
Azelastine—CYP3A4—Irinotecan—stomach cancer	0.00949	0.0269	CbGbCtD
Azelastine—ABCB1—Doxorubicin—stomach cancer	0.00866	0.0245	CbGbCtD
Azelastine—ABCB1—Methotrexate—stomach cancer	0.00839	0.0237	CbGbCtD
Azelastine—CYP2D6—Doxorubicin—stomach cancer	0.00816	0.0231	CbGbCtD
Azelastine—CYP3A4—Docetaxel—stomach cancer	0.00696	0.0197	CbGbCtD
Azelastine—CYP3A4—Doxorubicin—stomach cancer	0.00519	0.0147	CbGbCtD
Azelastine—HRH3—hematopoietic system—stomach cancer	0.00201	0.0836	CbGeAlD
Azelastine—HRH3—digestive system—stomach cancer	0.00139	0.0582	CbGeAlD
Azelastine—Loxapine—HRH4—stomach cancer	0.00076	0.336	CrCbGaD
Azelastine—Clozapine—HRH4—stomach cancer	0.000638	0.282	CrCbGaD
Azelastine—CYP2C19—hematopoietic system—stomach cancer	0.000607	0.0253	CbGeAlD
Azelastine—KCNH2—hematopoietic system—stomach cancer	0.000579	0.0242	CbGeAlD
Azelastine—CYP2C8—hematopoietic system—stomach cancer	0.00053	0.0221	CbGeAlD
Azelastine—CYP1A2—hematopoietic system—stomach cancer	0.000496	0.0207	CbGeAlD
Azelastine—CYP1A1—hematopoietic system—stomach cancer	0.000489	0.0204	CbGeAlD
Azelastine—CYP2A6—liver—stomach cancer	0.000489	0.0204	CbGeAlD
Azelastine—CYP3A5—hematopoietic system—stomach cancer	0.000478	0.02	CbGeAlD
Azelastine—ABCB1—blood vessel—stomach cancer	0.000477	0.0199	CbGeAlD
Azelastine—CYP2B6—hematopoietic system—stomach cancer	0.000476	0.0198	CbGeAlD
Azelastine—CYP2C9—hematopoietic system—stomach cancer	0.000471	0.0196	CbGeAlD
Azelastine—HRH1—hematopoietic system—stomach cancer	0.000464	0.0194	CbGeAlD
Azelastine—CYP1A1—epithelium—stomach cancer	0.000447	0.0187	CbGeAlD
Azelastine—CYP2E1—hematopoietic system—stomach cancer	0.000446	0.0186	CbGeAlD
Azelastine—HRH1—epithelium—stomach cancer	0.000424	0.0177	CbGeAlD
Azelastine—CYP2C19—digestive system—stomach cancer	0.000422	0.0176	CbGeAlD
Azelastine—HRH1—smooth muscle tissue—stomach cancer	0.000409	0.0171	CbGeAlD
Azelastine—CYP3A5—pancreas—stomach cancer	0.00039	0.0162	CbGeAlD
Azelastine—KCNH2—bone marrow—stomach cancer	0.000371	0.0155	CbGeAlD
Azelastine—CYP3A4—hematopoietic system—stomach cancer	0.000359	0.015	CbGeAlD
Azelastine—CYP2D6—hematopoietic system—stomach cancer	0.000353	0.0147	CbGeAlD
Azelastine—CYP2C19—endocrine gland—stomach cancer	0.000349	0.0146	CbGeAlD
Azelastine—CYP1A2—digestive system—stomach cancer	0.000345	0.0144	CbGeAlD
Azelastine—CYP1A1—digestive system—stomach cancer	0.00034	0.0142	CbGeAlD
Azelastine—CYP2B6—lymphoid tissue—stomach cancer	0.000335	0.014	CbGeAlD
Azelastine—KCNH2—endocrine gland—stomach cancer	0.000333	0.0139	CbGeAlD
Azelastine—CYP3A5—digestive system—stomach cancer	0.000333	0.0139	CbGeAlD
Azelastine—CYP2B6—digestive system—stomach cancer	0.000331	0.0138	CbGeAlD
Azelastine—CYP2C9—digestive system—stomach cancer	0.000327	0.0137	CbGeAlD
Azelastine—HRH1—digestive system—stomach cancer	0.000323	0.0135	CbGeAlD
Azelastine—CYP2C19—liver—stomach cancer	0.000315	0.0131	CbGeAlD
Azelastine—CYP2E1—lymphoid tissue—stomach cancer	0.000314	0.0131	CbGeAlD
Azelastine—CYP2E1—digestive system—stomach cancer	0.00031	0.0129	CbGeAlD
Azelastine—CYP2C8—endocrine gland—stomach cancer	0.000305	0.0127	CbGeAlD
Azelastine—CYP1A2—endocrine gland—stomach cancer	0.000285	0.0119	CbGeAlD
Azelastine—CYP1A1—endocrine gland—stomach cancer	0.000281	0.0117	CbGeAlD
Azelastine—CYP3A5—endocrine gland—stomach cancer	0.000275	0.0115	CbGeAlD
Azelastine—CYP2C8—liver—stomach cancer	0.000275	0.0115	CbGeAlD
Azelastine—CYP2B6—endocrine gland—stomach cancer	0.000273	0.0114	CbGeAlD
Azelastine—CYP2C9—endocrine gland—stomach cancer	0.000271	0.0113	CbGeAlD
Azelastine—HRH1—endocrine gland—stomach cancer	0.000267	0.0111	CbGeAlD
Azelastine—CYP1A2—liver—stomach cancer	0.000257	0.0107	CbGeAlD
Azelastine—CYP2E1—endocrine gland—stomach cancer	0.000256	0.0107	CbGeAlD
Azelastine—ABCB1—hematopoietic system—stomach cancer	0.000254	0.0106	CbGeAlD
Azelastine—CYP1A1—liver—stomach cancer	0.000254	0.0106	CbGeAlD
Azelastine—CYP3A4—digestive system—stomach cancer	0.00025	0.0104	CbGeAlD
Azelastine—CYP3A5—liver—stomach cancer	0.000248	0.0103	CbGeAlD
Azelastine—CYP2B6—liver—stomach cancer	0.000246	0.0103	CbGeAlD
Azelastine—CYP2D6—digestive system—stomach cancer	0.000246	0.0102	CbGeAlD
Azelastine—Loxapine—ADRB1—stomach cancer	0.000245	0.109	CrCbGaD
Azelastine—CYP2C9—liver—stomach cancer	0.000244	0.0102	CbGeAlD
Azelastine—ABCB1—epithelium—stomach cancer	0.000232	0.00969	CbGeAlD
Azelastine—CYP2E1—liver—stomach cancer	0.000231	0.00964	CbGeAlD
Azelastine—KCNH2—lymph node—stomach cancer	0.00023	0.0096	CbGeAlD
Azelastine—Loxapine—HTR1A—stomach cancer	0.00022	0.0972	CrCbGaD
Azelastine—Clozapine—CYP2A6—stomach cancer	0.000212	0.0939	CrCbGaD
Azelastine—ABCB1—pancreas—stomach cancer	0.000207	0.00863	CbGeAlD
Azelastine—CYP3A4—endocrine gland—stomach cancer	0.000206	0.00861	CbGeAlD
Azelastine—CYP2D6—endocrine gland—stomach cancer	0.000203	0.00847	CbGeAlD
Azelastine—Feeling abnormal—Irinotecan—stomach cancer	0.000201	0.00135	CcSEcCtD
Azelastine—Asthma—Epirubicin—stomach cancer	0.0002	0.00135	CcSEcCtD
Azelastine—Back pain—Docetaxel—stomach cancer	0.0002	0.00135	CcSEcCtD
Azelastine—Pain—Fluorouracil—stomach cancer	0.0002	0.00134	CcSEcCtD
Azelastine—Gastrointestinal pain—Irinotecan—stomach cancer	0.0002	0.00134	CcSEcCtD
Azelastine—Upper respiratory tract infection—Methotrexate—stomach cancer	0.000199	0.00134	CcSEcCtD
Azelastine—Dysgeusia—Capecitabine—stomach cancer	0.000196	0.00132	CcSEcCtD
Azelastine—CYP1A1—lymph node—stomach cancer	0.000194	0.00811	CbGeAlD
Azelastine—Back pain—Capecitabine—stomach cancer	0.000194	0.0013	CcSEcCtD
Azelastine—Abdominal pain—Irinotecan—stomach cancer	0.000193	0.0013	CcSEcCtD
Azelastine—Body temperature increased—Irinotecan—stomach cancer	0.000193	0.0013	CcSEcCtD
Azelastine—Feeling abnormal—Fluorouracil—stomach cancer	0.000193	0.0013	CcSEcCtD
Azelastine—Bronchitis—Epirubicin—stomach cancer	0.000193	0.00129	CcSEcCtD
Azelastine—Nasopharyngitis—Doxorubicin—stomach cancer	0.000192	0.00129	CcSEcCtD
Azelastine—Alanine aminotransferase increased—Doxorubicin—stomach cancer	0.000189	0.00127	CcSEcCtD
Azelastine—Vision blurred—Capecitabine—stomach cancer	0.000189	0.00127	CcSEcCtD
Azelastine—Upper respiratory tract infection—Epirubicin—stomach cancer	0.000186	0.00125	CcSEcCtD
Azelastine—CYP3A4—liver—stomach cancer	0.000186	0.00776	CbGeAlD
Azelastine—Ill-defined disorder—Capecitabine—stomach cancer	0.000186	0.00125	CcSEcCtD
Azelastine—Conjunctivitis—Methotrexate—stomach cancer	0.000186	0.00125	CcSEcCtD
Azelastine—Asthma—Doxorubicin—stomach cancer	0.000185	0.00125	CcSEcCtD
Azelastine—Pollakiuria—Epirubicin—stomach cancer	0.000185	0.00124	CcSEcCtD
Azelastine—Body temperature increased—Fluorouracil—stomach cancer	0.000185	0.00124	CcSEcCtD
Azelastine—HRH1—lymph node—stomach cancer	0.000184	0.00769	CbGeAlD
Azelastine—Clozapine—HTR1A—stomach cancer	0.000184	0.0816	CrCbGaD
Azelastine—CYP2D6—liver—stomach cancer	0.000183	0.00763	CbGeAlD
Azelastine—Palpitations—Docetaxel—stomach cancer	0.000183	0.00123	CcSEcCtD
Azelastine—Weight increased—Epirubicin—stomach cancer	0.000182	0.00123	CcSEcCtD
Azelastine—Haematuria—Methotrexate—stomach cancer	0.000182	0.00122	CcSEcCtD
Azelastine—Malaise—Capecitabine—stomach cancer	0.000181	0.00121	CcSEcCtD
Azelastine—Cough—Docetaxel—stomach cancer	0.000181	0.00121	CcSEcCtD
Azelastine—Epistaxis—Methotrexate—stomach cancer	0.00018	0.00121	CcSEcCtD
Azelastine—Vertigo—Capecitabine—stomach cancer	0.00018	0.00121	CcSEcCtD
Azelastine—Hypersensitivity—Irinotecan—stomach cancer	0.00018	0.00121	CcSEcCtD
Azelastine—ABCB1—lymphoid tissue—stomach cancer	0.000179	0.00746	CbGeAlD
Azelastine—Hypertension—Docetaxel—stomach cancer	0.000179	0.0012	CcSEcCtD
Azelastine—Bronchitis—Doxorubicin—stomach cancer	0.000178	0.0012	CcSEcCtD
Azelastine—Palpitations—Capecitabine—stomach cancer	0.000177	0.00119	CcSEcCtD
Azelastine—ABCB1—digestive system—stomach cancer	0.000177	0.00737	CbGeAlD
Azelastine—Chest pain—Docetaxel—stomach cancer	0.000176	0.00118	CcSEcCtD
Azelastine—Myalgia—Docetaxel—stomach cancer	0.000176	0.00118	CcSEcCtD
Azelastine—Asthenia—Irinotecan—stomach cancer	0.000175	0.00118	CcSEcCtD
Azelastine—Cough—Capecitabine—stomach cancer	0.000175	0.00118	CcSEcCtD
Azelastine—Conjunctivitis—Epirubicin—stomach cancer	0.000174	0.00117	CcSEcCtD
Azelastine—Hypertension—Capecitabine—stomach cancer	0.000173	0.00116	CcSEcCtD
Azelastine—Hypersensitivity—Fluorouracil—stomach cancer	0.000172	0.00116	CcSEcCtD
Azelastine—Dry mouth—Docetaxel—stomach cancer	0.000172	0.00116	CcSEcCtD
Azelastine—Upper respiratory tract infection—Doxorubicin—stomach cancer	0.000172	0.00116	CcSEcCtD
Azelastine—Pollakiuria—Doxorubicin—stomach cancer	0.000171	0.00115	CcSEcCtD
Azelastine—Myalgia—Capecitabine—stomach cancer	0.000171	0.00115	CcSEcCtD
Azelastine—Chest pain—Capecitabine—stomach cancer	0.000171	0.00115	CcSEcCtD
Azelastine—Haematuria—Epirubicin—stomach cancer	0.00017	0.00114	CcSEcCtD
Azelastine—Confusional state—Docetaxel—stomach cancer	0.00017	0.00114	CcSEcCtD
Azelastine—Pharyngitis—Methotrexate—stomach cancer	0.00017	0.00114	CcSEcCtD
Azelastine—Anxiety—Capecitabine—stomach cancer	0.00017	0.00114	CcSEcCtD
Azelastine—Anaphylactic shock—Docetaxel—stomach cancer	0.000169	0.00114	CcSEcCtD
Azelastine—Weight increased—Doxorubicin—stomach cancer	0.000169	0.00113	CcSEcCtD
Azelastine—Discomfort—Capecitabine—stomach cancer	0.000169	0.00113	CcSEcCtD
Azelastine—Epistaxis—Epirubicin—stomach cancer	0.000169	0.00113	CcSEcCtD
Azelastine—Infection—Docetaxel—stomach cancer	0.000168	0.00113	CcSEcCtD
Azelastine—Sinusitis—Epirubicin—stomach cancer	0.000168	0.00113	CcSEcCtD
Azelastine—Diarrhoea—Irinotecan—stomach cancer	0.000167	0.00112	CcSEcCtD
Azelastine—Dry mouth—Capecitabine—stomach cancer	0.000167	0.00112	CcSEcCtD
Azelastine—Pruritus—Fluorouracil—stomach cancer	0.000166	0.00111	CcSEcCtD
Azelastine—Visual impairment—Methotrexate—stomach cancer	0.000165	0.00111	CcSEcCtD
Azelastine—Confusional state—Capecitabine—stomach cancer	0.000165	0.00111	CcSEcCtD
Azelastine—Tachycardia—Docetaxel—stomach cancer	0.000165	0.00111	CcSEcCtD
Azelastine—ABCB1—bone marrow—stomach cancer	0.000163	0.0068	CbGeAlD
Azelastine—Infection—Capecitabine—stomach cancer	0.000163	0.00109	CcSEcCtD
Azelastine—Dizziness—Irinotecan—stomach cancer	0.000162	0.00109	CcSEcCtD
Azelastine—Rhinitis—Epirubicin—stomach cancer	0.000161	0.00108	CcSEcCtD
Azelastine—Conjunctivitis—Doxorubicin—stomach cancer	0.000161	0.00108	CcSEcCtD
Azelastine—Eye disorder—Methotrexate—stomach cancer	0.00016	0.00108	CcSEcCtD
Azelastine—Diarrhoea—Fluorouracil—stomach cancer	0.00016	0.00108	CcSEcCtD
Azelastine—Tachycardia—Capecitabine—stomach cancer	0.00016	0.00107	CcSEcCtD
Azelastine—Hypoaesthesia—Epirubicin—stomach cancer	0.00016	0.00107	CcSEcCtD
Azelastine—Pharyngitis—Epirubicin—stomach cancer	0.000159	0.00107	CcSEcCtD
Azelastine—Haematuria—Doxorubicin—stomach cancer	0.000158	0.00106	CcSEcCtD
Azelastine—Epistaxis—Doxorubicin—stomach cancer	0.000156	0.00105	CcSEcCtD
Azelastine—Vomiting—Irinotecan—stomach cancer	0.000155	0.00104	CcSEcCtD
Azelastine—Sinusitis—Doxorubicin—stomach cancer	0.000155	0.00104	CcSEcCtD
Azelastine—Dizziness—Fluorouracil—stomach cancer	0.000155	0.00104	CcSEcCtD
Azelastine—Visual impairment—Epirubicin—stomach cancer	0.000155	0.00104	CcSEcCtD
Azelastine—Rash—Irinotecan—stomach cancer	0.000154	0.00104	CcSEcCtD
Azelastine—Dermatitis—Irinotecan—stomach cancer	0.000154	0.00103	CcSEcCtD
Azelastine—Musculoskeletal discomfort—Docetaxel—stomach cancer	0.000154	0.00103	CcSEcCtD
Azelastine—Headache—Irinotecan—stomach cancer	0.000153	0.00103	CcSEcCtD
Azelastine—Paraesthesia—Docetaxel—stomach cancer	0.000152	0.00102	CcSEcCtD
Azelastine—Dyspnoea—Docetaxel—stomach cancer	0.000151	0.00101	CcSEcCtD
Azelastine—Somnolence—Docetaxel—stomach cancer	0.00015	0.00101	CcSEcCtD
Azelastine—Eye disorder—Epirubicin—stomach cancer	0.00015	0.00101	CcSEcCtD
Azelastine—Musculoskeletal discomfort—Capecitabine—stomach cancer	0.000149	0.001	CcSEcCtD
Azelastine—Flushing—Epirubicin—stomach cancer	0.000149	0.001	CcSEcCtD
Azelastine—Vomiting—Fluorouracil—stomach cancer	0.000149	0.001	CcSEcCtD
Azelastine—Rhinitis—Doxorubicin—stomach cancer	0.000149	0.001	CcSEcCtD
Azelastine—Hypoaesthesia—Doxorubicin—stomach cancer	0.000148	0.000992	CcSEcCtD
Azelastine—Rash—Fluorouracil—stomach cancer	0.000148	0.000992	CcSEcCtD
Azelastine—Dermatitis—Fluorouracil—stomach cancer	0.000147	0.000991	CcSEcCtD
Azelastine—Pharyngitis—Doxorubicin—stomach cancer	0.000147	0.00099	CcSEcCtD
Azelastine—Paraesthesia—Capecitabine—stomach cancer	0.000147	0.000987	CcSEcCtD
Azelastine—Headache—Fluorouracil—stomach cancer	0.000147	0.000985	CcSEcCtD
Azelastine—Dysgeusia—Methotrexate—stomach cancer	0.000146	0.000982	CcSEcCtD
Azelastine—ABCB1—endocrine gland—stomach cancer	0.000146	0.00609	CbGeAlD
Azelastine—Dyspnoea—Capecitabine—stomach cancer	0.000146	0.00098	CcSEcCtD
Azelastine—Fatigue—Docetaxel—stomach cancer	0.000146	0.000979	CcSEcCtD
Azelastine—Nausea—Irinotecan—stomach cancer	0.000145	0.000975	CcSEcCtD
Azelastine—Constipation—Docetaxel—stomach cancer	0.000144	0.000971	CcSEcCtD
Azelastine—Pain—Docetaxel—stomach cancer	0.000144	0.000971	CcSEcCtD
Azelastine—Back pain—Methotrexate—stomach cancer	0.000144	0.00097	CcSEcCtD
Azelastine—Visual impairment—Doxorubicin—stomach cancer	0.000143	0.000961	CcSEcCtD
Azelastine—Fatigue—Capecitabine—stomach cancer	0.000141	0.000948	CcSEcCtD
Azelastine—Vision blurred—Methotrexate—stomach cancer	0.000141	0.000945	CcSEcCtD
Azelastine—Constipation—Capecitabine—stomach cancer	0.00014	0.00094	CcSEcCtD
Azelastine—Pain—Capecitabine—stomach cancer	0.00014	0.00094	CcSEcCtD
Azelastine—Feeling abnormal—Docetaxel—stomach cancer	0.000139	0.000935	CcSEcCtD
Azelastine—Nausea—Fluorouracil—stomach cancer	0.000139	0.000934	CcSEcCtD
Azelastine—Eye disorder—Doxorubicin—stomach cancer	0.000139	0.000932	CcSEcCtD
Azelastine—Ill-defined disorder—Methotrexate—stomach cancer	0.000138	0.00093	CcSEcCtD
Azelastine—Gastrointestinal pain—Docetaxel—stomach cancer	0.000138	0.000928	CcSEcCtD
Azelastine—Flushing—Doxorubicin—stomach cancer	0.000138	0.000925	CcSEcCtD
Azelastine—Tension—Epirubicin—stomach cancer	0.000137	0.000921	CcSEcCtD
Azelastine—Dysgeusia—Epirubicin—stomach cancer	0.000137	0.000919	CcSEcCtD
Azelastine—Nervousness—Epirubicin—stomach cancer	0.000136	0.000911	CcSEcCtD
Azelastine—Back pain—Epirubicin—stomach cancer	0.000135	0.000907	CcSEcCtD
Azelastine—Feeling abnormal—Capecitabine—stomach cancer	0.000135	0.000906	CcSEcCtD
Azelastine—Malaise—Methotrexate—stomach cancer	0.000135	0.000904	CcSEcCtD
Azelastine—Vertigo—Methotrexate—stomach cancer	0.000134	0.000901	CcSEcCtD
Azelastine—Gastrointestinal pain—Capecitabine—stomach cancer	0.000134	0.000899	CcSEcCtD
Azelastine—Body temperature increased—Docetaxel—stomach cancer	0.000134	0.000897	CcSEcCtD
Azelastine—Abdominal pain—Docetaxel—stomach cancer	0.000134	0.000897	CcSEcCtD
Azelastine—ABCB1—liver—stomach cancer	0.000132	0.00549	CbGeAlD
Azelastine—Vision blurred—Epirubicin—stomach cancer	0.000132	0.000884	CcSEcCtD
Azelastine—Cough—Methotrexate—stomach cancer	0.00013	0.000875	CcSEcCtD
Azelastine—Ill-defined disorder—Epirubicin—stomach cancer	0.00013	0.00087	CcSEcCtD
Azelastine—Abdominal pain—Capecitabine—stomach cancer	0.000129	0.000869	CcSEcCtD
Azelastine—Body temperature increased—Capecitabine—stomach cancer	0.000129	0.000869	CcSEcCtD
Azelastine—Agitation—Epirubicin—stomach cancer	0.000128	0.000862	CcSEcCtD
Azelastine—Myalgia—Methotrexate—stomach cancer	0.000127	0.000853	CcSEcCtD
Azelastine—Chest pain—Methotrexate—stomach cancer	0.000127	0.000853	CcSEcCtD
Azelastine—Tension—Doxorubicin—stomach cancer	0.000127	0.000852	CcSEcCtD
Azelastine—Dysgeusia—Doxorubicin—stomach cancer	0.000127	0.00085	CcSEcCtD
Azelastine—Malaise—Epirubicin—stomach cancer	0.000126	0.000846	CcSEcCtD
Azelastine—Discomfort—Methotrexate—stomach cancer	0.000126	0.000843	CcSEcCtD
Azelastine—Nervousness—Doxorubicin—stomach cancer	0.000125	0.000843	CcSEcCtD
Azelastine—Vertigo—Epirubicin—stomach cancer	0.000125	0.000843	CcSEcCtD
Azelastine—Back pain—Doxorubicin—stomach cancer	0.000125	0.00084	CcSEcCtD
Azelastine—Hypersensitivity—Docetaxel—stomach cancer	0.000124	0.000836	CcSEcCtD
Azelastine—Palpitations—Epirubicin—stomach cancer	0.000123	0.000829	CcSEcCtD
Azelastine—Confusional state—Methotrexate—stomach cancer	0.000123	0.000825	CcSEcCtD
Azelastine—Cough—Epirubicin—stomach cancer	0.000122	0.000819	CcSEcCtD
Azelastine—Anaphylactic shock—Methotrexate—stomach cancer	0.000122	0.000818	CcSEcCtD
Azelastine—Vision blurred—Doxorubicin—stomach cancer	0.000122	0.000818	CcSEcCtD
Azelastine—Asthenia—Docetaxel—stomach cancer	0.000121	0.000814	CcSEcCtD
Azelastine—Infection—Methotrexate—stomach cancer	0.000121	0.000813	CcSEcCtD
Azelastine—Hypertension—Epirubicin—stomach cancer	0.000121	0.00081	CcSEcCtD
Azelastine—Hypersensitivity—Capecitabine—stomach cancer	0.000121	0.00081	CcSEcCtD
Azelastine—Ill-defined disorder—Doxorubicin—stomach cancer	0.00012	0.000805	CcSEcCtD
Azelastine—Pruritus—Docetaxel—stomach cancer	0.00012	0.000803	CcSEcCtD
Azelastine—Chest pain—Epirubicin—stomach cancer	0.000119	0.000799	CcSEcCtD
Azelastine—Myalgia—Epirubicin—stomach cancer	0.000119	0.000799	CcSEcCtD
Azelastine—Agitation—Doxorubicin—stomach cancer	0.000119	0.000798	CcSEcCtD
Azelastine—Anxiety—Epirubicin—stomach cancer	0.000118	0.000796	CcSEcCtD
Azelastine—Discomfort—Epirubicin—stomach cancer	0.000117	0.000789	CcSEcCtD
Azelastine—Asthenia—Capecitabine—stomach cancer	0.000117	0.000789	CcSEcCtD
Azelastine—Malaise—Doxorubicin—stomach cancer	0.000117	0.000783	CcSEcCtD
Azelastine—Dry mouth—Epirubicin—stomach cancer	0.000116	0.000781	CcSEcCtD
Azelastine—Vertigo—Doxorubicin—stomach cancer	0.000116	0.00078	CcSEcCtD
Azelastine—Pruritus—Capecitabine—stomach cancer	0.000116	0.000778	CcSEcCtD
Azelastine—Diarrhoea—Docetaxel—stomach cancer	0.000116	0.000777	CcSEcCtD
Azelastine—Confusional state—Epirubicin—stomach cancer	0.000115	0.000772	CcSEcCtD
Azelastine—Palpitations—Doxorubicin—stomach cancer	0.000114	0.000767	CcSEcCtD
Azelastine—Anaphylactic shock—Epirubicin—stomach cancer	0.000114	0.000766	CcSEcCtD
Azelastine—Infection—Epirubicin—stomach cancer	0.000113	0.000761	CcSEcCtD
Azelastine—Cough—Doxorubicin—stomach cancer	0.000113	0.000757	CcSEcCtD
Azelastine—Diarrhoea—Capecitabine—stomach cancer	0.000112	0.000752	CcSEcCtD
Azelastine—Dizziness—Docetaxel—stomach cancer	0.000112	0.000751	CcSEcCtD
Azelastine—Hypertension—Doxorubicin—stomach cancer	0.000112	0.000749	CcSEcCtD
Azelastine—Tachycardia—Epirubicin—stomach cancer	0.000111	0.000747	CcSEcCtD
Azelastine—Musculoskeletal discomfort—Methotrexate—stomach cancer	0.000111	0.000745	CcSEcCtD
Azelastine—Myalgia—Doxorubicin—stomach cancer	0.00011	0.000739	CcSEcCtD
Azelastine—Chest pain—Doxorubicin—stomach cancer	0.00011	0.000739	CcSEcCtD
Azelastine—Anxiety—Doxorubicin—stomach cancer	0.00011	0.000736	CcSEcCtD
Azelastine—Paraesthesia—Methotrexate—stomach cancer	0.000109	0.000735	CcSEcCtD
Azelastine—Discomfort—Doxorubicin—stomach cancer	0.000109	0.00073	CcSEcCtD
Azelastine—Dyspnoea—Methotrexate—stomach cancer	0.000109	0.000729	CcSEcCtD
Azelastine—Somnolence—Methotrexate—stomach cancer	0.000108	0.000727	CcSEcCtD
Azelastine—Dizziness—Capecitabine—stomach cancer	0.000108	0.000727	CcSEcCtD
Azelastine—Dry mouth—Doxorubicin—stomach cancer	0.000108	0.000723	CcSEcCtD
Azelastine—Vomiting—Docetaxel—stomach cancer	0.000107	0.000722	CcSEcCtD
Azelastine—Rash—Docetaxel—stomach cancer	0.000107	0.000716	CcSEcCtD
Azelastine—Dermatitis—Docetaxel—stomach cancer	0.000106	0.000715	CcSEcCtD
Azelastine—Confusional state—Doxorubicin—stomach cancer	0.000106	0.000714	CcSEcCtD
Azelastine—Headache—Docetaxel—stomach cancer	0.000106	0.000711	CcSEcCtD
Azelastine—Anaphylactic shock—Doxorubicin—stomach cancer	0.000105	0.000708	CcSEcCtD
Azelastine—Fatigue—Methotrexate—stomach cancer	0.000105	0.000705	CcSEcCtD
Azelastine—Infection—Doxorubicin—stomach cancer	0.000105	0.000704	CcSEcCtD
Azelastine—Pain—Methotrexate—stomach cancer	0.000104	0.0007	CcSEcCtD
Azelastine—Vomiting—Capecitabine—stomach cancer	0.000104	0.000699	CcSEcCtD
Azelastine—Musculoskeletal discomfort—Epirubicin—stomach cancer	0.000104	0.000698	CcSEcCtD
Azelastine—Rash—Capecitabine—stomach cancer	0.000103	0.000693	CcSEcCtD
Azelastine—Dermatitis—Capecitabine—stomach cancer	0.000103	0.000692	CcSEcCtD
Azelastine—Tachycardia—Doxorubicin—stomach cancer	0.000103	0.000691	CcSEcCtD
Azelastine—Headache—Capecitabine—stomach cancer	0.000102	0.000688	CcSEcCtD
Azelastine—Paraesthesia—Epirubicin—stomach cancer	0.000102	0.000687	CcSEcCtD
Azelastine—Dyspnoea—Epirubicin—stomach cancer	0.000102	0.000683	CcSEcCtD
Azelastine—Somnolence—Epirubicin—stomach cancer	0.000101	0.000681	CcSEcCtD
Azelastine—ABCB1—lymph node—stomach cancer	0.000101	0.00421	CbGeAlD
Azelastine—Nausea—Docetaxel—stomach cancer	0.0001	0.000674	CcSEcCtD
Azelastine—Feeling abnormal—Methotrexate—stomach cancer	0.0001	0.000674	CcSEcCtD
Azelastine—Gastrointestinal pain—Methotrexate—stomach cancer	9.96e-05	0.000669	CcSEcCtD
Azelastine—Fatigue—Epirubicin—stomach cancer	9.82e-05	0.00066	CcSEcCtD
Azelastine—Constipation—Epirubicin—stomach cancer	9.75e-05	0.000655	CcSEcCtD
Azelastine—Pain—Epirubicin—stomach cancer	9.75e-05	0.000655	CcSEcCtD
Azelastine—Nausea—Capecitabine—stomach cancer	9.72e-05	0.000653	CcSEcCtD
Azelastine—Body temperature increased—Methotrexate—stomach cancer	9.63e-05	0.000647	CcSEcCtD
Azelastine—Abdominal pain—Methotrexate—stomach cancer	9.63e-05	0.000647	CcSEcCtD
Azelastine—Musculoskeletal discomfort—Doxorubicin—stomach cancer	9.61e-05	0.000645	CcSEcCtD
Azelastine—Paraesthesia—Doxorubicin—stomach cancer	9.47e-05	0.000636	CcSEcCtD
Azelastine—Dyspnoea—Doxorubicin—stomach cancer	9.4e-05	0.000632	CcSEcCtD
Azelastine—Feeling abnormal—Epirubicin—stomach cancer	9.39e-05	0.000631	CcSEcCtD
Azelastine—Somnolence—Doxorubicin—stomach cancer	9.37e-05	0.00063	CcSEcCtD
Azelastine—Gastrointestinal pain—Epirubicin—stomach cancer	9.32e-05	0.000626	CcSEcCtD
Azelastine—Fatigue—Doxorubicin—stomach cancer	9.09e-05	0.000611	CcSEcCtD
Azelastine—Pain—Doxorubicin—stomach cancer	9.02e-05	0.000606	CcSEcCtD
Azelastine—Constipation—Doxorubicin—stomach cancer	9.02e-05	0.000606	CcSEcCtD
Azelastine—Body temperature increased—Epirubicin—stomach cancer	9.01e-05	0.000605	CcSEcCtD
Azelastine—Abdominal pain—Epirubicin—stomach cancer	9.01e-05	0.000605	CcSEcCtD
Azelastine—Hypersensitivity—Methotrexate—stomach cancer	8.97e-05	0.000603	CcSEcCtD
Azelastine—Asthenia—Methotrexate—stomach cancer	8.74e-05	0.000587	CcSEcCtD
Azelastine—Feeling abnormal—Doxorubicin—stomach cancer	8.69e-05	0.000584	CcSEcCtD
Azelastine—Gastrointestinal pain—Doxorubicin—stomach cancer	8.62e-05	0.000579	CcSEcCtD
Azelastine—Pruritus—Methotrexate—stomach cancer	8.62e-05	0.000579	CcSEcCtD
Azelastine—Hypersensitivity—Epirubicin—stomach cancer	8.4e-05	0.000564	CcSEcCtD
Azelastine—Body temperature increased—Doxorubicin—stomach cancer	8.34e-05	0.00056	CcSEcCtD
Azelastine—Abdominal pain—Doxorubicin—stomach cancer	8.34e-05	0.00056	CcSEcCtD
Azelastine—Diarrhoea—Methotrexate—stomach cancer	8.33e-05	0.00056	CcSEcCtD
Azelastine—Asthenia—Epirubicin—stomach cancer	8.18e-05	0.000549	CcSEcCtD
Azelastine—Pruritus—Epirubicin—stomach cancer	8.06e-05	0.000542	CcSEcCtD
Azelastine—Dizziness—Methotrexate—stomach cancer	8.05e-05	0.000541	CcSEcCtD
Azelastine—Diarrhoea—Epirubicin—stomach cancer	7.8e-05	0.000524	CcSEcCtD
Azelastine—Hypersensitivity—Doxorubicin—stomach cancer	7.77e-05	0.000522	CcSEcCtD
Azelastine—Vomiting—Methotrexate—stomach cancer	7.74e-05	0.00052	CcSEcCtD
Azelastine—Rash—Methotrexate—stomach cancer	7.68e-05	0.000516	CcSEcCtD
Azelastine—Dermatitis—Methotrexate—stomach cancer	7.67e-05	0.000515	CcSEcCtD
Azelastine—Headache—Methotrexate—stomach cancer	7.63e-05	0.000513	CcSEcCtD
Azelastine—Asthenia—Doxorubicin—stomach cancer	7.57e-05	0.000508	CcSEcCtD
Azelastine—Dizziness—Epirubicin—stomach cancer	7.54e-05	0.000506	CcSEcCtD
Azelastine—Pruritus—Doxorubicin—stomach cancer	7.46e-05	0.000501	CcSEcCtD
Azelastine—Vomiting—Epirubicin—stomach cancer	7.25e-05	0.000487	CcSEcCtD
Azelastine—Nausea—Methotrexate—stomach cancer	7.23e-05	0.000486	CcSEcCtD
Azelastine—Diarrhoea—Doxorubicin—stomach cancer	7.21e-05	0.000485	CcSEcCtD
Azelastine—Rash—Epirubicin—stomach cancer	7.19e-05	0.000483	CcSEcCtD
Azelastine—Dermatitis—Epirubicin—stomach cancer	7.18e-05	0.000482	CcSEcCtD
Azelastine—Headache—Epirubicin—stomach cancer	7.14e-05	0.00048	CcSEcCtD
Azelastine—Dizziness—Doxorubicin—stomach cancer	6.97e-05	0.000468	CcSEcCtD
Azelastine—Nausea—Epirubicin—stomach cancer	6.77e-05	0.000455	CcSEcCtD
Azelastine—Vomiting—Doxorubicin—stomach cancer	6.7e-05	0.00045	CcSEcCtD
Azelastine—Rash—Doxorubicin—stomach cancer	6.65e-05	0.000447	CcSEcCtD
Azelastine—Dermatitis—Doxorubicin—stomach cancer	6.64e-05	0.000446	CcSEcCtD
Azelastine—Headache—Doxorubicin—stomach cancer	6.61e-05	0.000444	CcSEcCtD
Azelastine—Nausea—Doxorubicin—stomach cancer	6.26e-05	0.000421	CcSEcCtD
Azelastine—CYP2E1—Metabolism—GSTM1—stomach cancer	6.67e-06	7.41e-05	CbGpPWpGaD
Azelastine—CYP3A5—Metabolism—GSTM1—stomach cancer	6.65e-06	7.4e-05	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—CD44—stomach cancer	6.55e-06	7.28e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—FYN—stomach cancer	6.51e-06	7.24e-05	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	6.51e-06	7.24e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—SREBF2—stomach cancer	6.49e-06	7.21e-05	CbGpPWpGaD
Azelastine—HRH3—Signaling Pathways—HRAS—stomach cancer	6.47e-06	7.19e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	6.45e-06	7.17e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—RORA—stomach cancer	6.41e-06	7.13e-05	CbGpPWpGaD
Azelastine—CYP2B6—Metabolism—ERCC2—stomach cancer	6.4e-06	7.12e-05	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—PPP2R1A—stomach cancer	6.39e-06	7.11e-05	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism—TYMS—stomach cancer	6.36e-06	7.07e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—GSTT1—stomach cancer	6.29e-06	7e-05	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism—GSTM1—stomach cancer	6.29e-06	6.99e-05	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—GSTP1—stomach cancer	6.27e-06	6.97e-05	CbGpPWpGaD
Azelastine—CYP2E1—Metabolism—ERCC2—stomach cancer	6.27e-06	6.97e-05	CbGpPWpGaD
Azelastine—CYP3A5—Metabolism—ERCC2—stomach cancer	6.26e-06	6.96e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—CYP2A6—stomach cancer	6.22e-06	6.92e-05	CbGpPWpGaD
Azelastine—HRH3—Signaling Pathways—IL6—stomach cancer	6.19e-06	6.88e-05	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—HMOX1—stomach cancer	6.19e-06	6.88e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—IRS2—stomach cancer	6.19e-06	6.88e-05	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—CD44—stomach cancer	6.17e-06	6.86e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling by GPCR—CXCL8—stomach cancer	6.16e-06	6.85e-05	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—CD44—stomach cancer	6.12e-06	6.8e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—FGFR2—stomach cancer	6.11e-06	6.8e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—AKR1C3—stomach cancer	6.05e-06	6.73e-05	CbGpPWpGaD
Azelastine—CYP2A6—Metabolism—PPARG—stomach cancer	6.05e-06	6.72e-05	CbGpPWpGaD
Azelastine—CYP2B6—Metabolism—MTHFR—stomach cancer	6.02e-06	6.69e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—ALDOB—stomach cancer	6e-06	6.68e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—CAV1—stomach cancer	6e-06	6.67e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—APOA1—stomach cancer	5.98e-06	6.65e-05	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	5.94e-06	6.6e-05	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism—ERCC2—stomach cancer	5.91e-06	6.57e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—ENO1—stomach cancer	5.9e-06	6.56e-05	CbGpPWpGaD
Azelastine—CYP2E1—Metabolism—MTHFR—stomach cancer	5.89e-06	6.55e-05	CbGpPWpGaD
Azelastine—CYP3A5—Metabolism—MTHFR—stomach cancer	5.88e-06	6.54e-05	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—TYMS—stomach cancer	5.83e-06	6.48e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—stomach cancer	5.8e-06	6.45e-05	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—GSTM1—stomach cancer	5.76e-06	6.41e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—PRKCB—stomach cancer	5.71e-06	6.35e-05	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—PPP2R1A—stomach cancer	5.71e-06	6.35e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—IL6ST—stomach cancer	5.69e-06	6.32e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—IRS2—stomach cancer	5.6e-06	6.23e-05	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—GSTP1—stomach cancer	5.6e-06	6.22e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—ALOX5—stomach cancer	5.58e-06	6.21e-05	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—PPP2R1A—stomach cancer	5.57e-06	6.19e-05	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism—MTHFR—stomach cancer	5.56e-06	6.18e-05	CbGpPWpGaD
Azelastine—CYP2B6—Metabolism—CAV1—stomach cancer	5.55e-06	6.17e-05	CbGpPWpGaD
Azelastine—CYP2B6—Metabolism—APOA1—stomach cancer	5.54e-06	6.16e-05	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—HMOX1—stomach cancer	5.52e-06	6.14e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—DPYD—stomach cancer	5.49e-06	6.11e-05	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—GSTP1—stomach cancer	5.46e-06	6.08e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—APC—stomach cancer	5.46e-06	6.07e-05	CbGpPWpGaD
Azelastine—CYP2A6—Metabolism—ALB—stomach cancer	5.44e-06	6.05e-05	CbGpPWpGaD
Azelastine—CYP2E1—Metabolism—CAV1—stomach cancer	5.44e-06	6.04e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—CAV1—stomach cancer	5.43e-06	6.04e-05	CbGpPWpGaD
Azelastine—CYP3A5—Metabolism—CAV1—stomach cancer	5.42e-06	6.03e-05	CbGpPWpGaD
Azelastine—CYP2E1—Metabolism—APOA1—stomach cancer	5.42e-06	6.03e-05	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—ERCC2—stomach cancer	5.42e-06	6.03e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—APOA1—stomach cancer	5.42e-06	6.02e-05	CbGpPWpGaD
Azelastine—CYP3A5—Metabolism—APOA1—stomach cancer	5.41e-06	6.02e-05	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—HMOX1—stomach cancer	5.39e-06	5.99e-05	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—PPP2R1A—stomach cancer	5.25e-06	5.84e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling by GPCR—MAPK3—stomach cancer	5.23e-06	5.82e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—CD44—stomach cancer	5.23e-06	5.82e-05	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—TYMS—stomach cancer	5.2e-06	5.79e-05	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—PPP2R1A—stomach cancer	5.2e-06	5.79e-05	CbGpPWpGaD
Azelastine—CYP2A6—Metabolism—NOS3—stomach cancer	5.2e-06	5.78e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—PRKCB—stomach cancer	5.17e-06	5.75e-05	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—GSTP1—stomach cancer	5.15e-06	5.73e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—IL6ST—stomach cancer	5.15e-06	5.72e-05	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—GSTM1—stomach cancer	5.14e-06	5.72e-05	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism—CAV1—stomach cancer	5.12e-06	5.7e-05	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism—APOA1—stomach cancer	5.11e-06	5.69e-05	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—GSTP1—stomach cancer	5.1e-06	5.68e-05	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—MTHFR—stomach cancer	5.09e-06	5.66e-05	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—TYMS—stomach cancer	5.08e-06	5.65e-05	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—HMOX1—stomach cancer	5.08e-06	5.65e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	5.07e-06	5.64e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—IL6R—stomach cancer	5.07e-06	5.64e-05	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—HMOX1—stomach cancer	5.03e-06	5.6e-05	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—GSTM1—stomach cancer	5.02e-06	5.58e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling by GPCR—MAPK1—stomach cancer	4.98e-06	5.53e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling by GPCR—EGFR—stomach cancer	4.98e-06	5.53e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—APC—stomach cancer	4.94e-06	5.5e-05	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	4.9e-06	5.44e-05	CbGpPWpGaD
Azelastine—CYP2B6—Metabolism—PPARG—stomach cancer	4.88e-06	5.42e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—GSTT1—stomach cancer	4.86e-06	5.4e-05	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—ERCC2—stomach cancer	4.84e-06	5.38e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—CYP2A6—stomach cancer	4.8e-06	5.34e-05	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—TYMS—stomach cancer	4.79e-06	5.32e-05	CbGpPWpGaD
Azelastine—CYP2E1—Metabolism—PPARG—stomach cancer	4.78e-06	5.31e-05	CbGpPWpGaD
Azelastine—CYP3A5—Metabolism—PPARG—stomach cancer	4.77e-06	5.3e-05	CbGpPWpGaD
Azelastine—CYP2A6—Metabolism—PTGS2—stomach cancer	4.76e-06	5.29e-05	CbGpPWpGaD
Azelastine—ADRA1B—GPCR downstream signaling—PIK3CA—stomach cancer	4.76e-06	5.29e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—SERPINE1—stomach cancer	4.75e-06	5.28e-05	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—TYMS—stomach cancer	4.75e-06	5.28e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling by GPCR—MAPK3—stomach cancer	4.74e-06	5.27e-05	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—GSTM1—stomach cancer	4.73e-06	5.26e-05	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—ERCC2—stomach cancer	4.72e-06	5.25e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling by GPCR—KRAS—stomach cancer	4.7e-06	5.23e-05	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—CAV1—stomach cancer	4.7e-06	5.22e-05	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—GSTM1—stomach cancer	4.69e-06	5.22e-05	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—APOA1—stomach cancer	4.69e-06	5.21e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—AKR1C3—stomach cancer	4.67e-06	5.19e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—IL6R—stomach cancer	4.59e-06	5.11e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—RHOA—stomach cancer	4.58e-06	5.09e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—ENO1—stomach cancer	4.55e-06	5.06e-05	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—MTHFR—stomach cancer	4.55e-06	5.06e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—NOS3—stomach cancer	4.53e-06	5.04e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling by GPCR—MAPK1—stomach cancer	4.51e-06	5.01e-05	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism—PPARG—stomach cancer	4.51e-06	5.01e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling by GPCR—EGFR—stomach cancer	4.51e-06	5.01e-05	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	4.49e-06	4.99e-05	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—ERCC2—stomach cancer	4.45e-06	4.95e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—PPP2R1A—stomach cancer	4.45e-06	4.94e-05	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—MTHFR—stomach cancer	4.44e-06	4.93e-05	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—ERCC2—stomach cancer	4.41e-06	4.9e-05	CbGpPWpGaD
Azelastine—CYP2B6—Metabolism—ALB—stomach cancer	4.39e-06	4.88e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—GSTP1—stomach cancer	4.36e-06	4.85e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling by GPCR—PIK3CA—stomach cancer	4.32e-06	4.8e-05	CbGpPWpGaD
Azelastine—HRH1—GPCR downstream signaling—PIK3CA—stomach cancer	4.31e-06	4.79e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—HMOX1—stomach cancer	4.3e-06	4.78e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—SERPINE1—stomach cancer	4.3e-06	4.78e-05	CbGpPWpGaD
Azelastine—CYP2E1—Metabolism—ALB—stomach cancer	4.3e-06	4.78e-05	CbGpPWpGaD
Azelastine—CYP3A5—Metabolism—ALB—stomach cancer	4.29e-06	4.77e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling by GPCR—KRAS—stomach cancer	4.26e-06	4.73e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—ERBB2—stomach cancer	4.24e-06	4.72e-05	CbGpPWpGaD
Azelastine—CYP2B6—Metabolism—NOS3—stomach cancer	4.2e-06	4.67e-05	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—CAV1—stomach cancer	4.19e-06	4.66e-05	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—APOA1—stomach cancer	4.18e-06	4.65e-05	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—MTHFR—stomach cancer	4.18e-06	4.65e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—RHOA—stomach cancer	4.15e-06	4.61e-05	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—MTHFR—stomach cancer	4.15e-06	4.61e-05	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—PPARG—stomach cancer	4.13e-06	4.59e-05	CbGpPWpGaD
Azelastine—CYP2E1—Metabolism—NOS3—stomach cancer	4.11e-06	4.57e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—NOS3—stomach cancer	4.1e-06	4.56e-05	CbGpPWpGaD
Azelastine—CYP3A5—Metabolism—NOS3—stomach cancer	4.1e-06	4.56e-05	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—CAV1—stomach cancer	4.09e-06	4.55e-05	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—APOA1—stomach cancer	4.08e-06	4.54e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—TYMS—stomach cancer	4.06e-06	4.51e-05	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism—ALB—stomach cancer	4.05e-06	4.5e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—CD44—stomach cancer	4.04e-06	4.49e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—CXCL8—stomach cancer	4.02e-06	4.47e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—GSTM1—stomach cancer	4.01e-06	4.46e-05	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	4.01e-06	4.45e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling by GPCR—HRAS—stomach cancer	4e-06	4.44e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—CDKN1B—stomach cancer	3.93e-06	4.37e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling by GPCR—PIK3CA—stomach cancer	3.91e-06	4.35e-05	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism—NOS3—stomach cancer	3.87e-06	4.31e-05	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—CAV1—stomach cancer	3.86e-06	4.29e-05	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—APOA1—stomach cancer	3.85e-06	4.28e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—ERBB2—stomach cancer	3.84e-06	4.27e-05	CbGpPWpGaD
Azelastine—CYP2B6—Metabolism—PTGS2—stomach cancer	3.84e-06	4.27e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling by GPCR—IL6—stomach cancer	3.82e-06	4.25e-05	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—CAV1—stomach cancer	3.82e-06	4.25e-05	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—APOA1—stomach cancer	3.82e-06	4.24e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—ERCC2—stomach cancer	3.77e-06	4.19e-05	CbGpPWpGaD
Azelastine—CYP2E1—Metabolism—PTGS2—stomach cancer	3.76e-06	4.18e-05	CbGpPWpGaD
Azelastine—CYP3A5—Metabolism—PTGS2—stomach cancer	3.75e-06	4.17e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—CCND1—stomach cancer	3.75e-06	4.17e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—JUN—stomach cancer	3.74e-06	4.16e-05	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—ALB—stomach cancer	3.71e-06	4.13e-05	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—PPARG—stomach cancer	3.69e-06	4.1e-05	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	3.65e-06	4.06e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—CXCL8—stomach cancer	3.64e-06	4.05e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—MMP9—stomach cancer	3.64e-06	4.05e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—CDKN1A—stomach cancer	3.63e-06	4.03e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling by GPCR—HRAS—stomach cancer	3.62e-06	4.02e-05	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—PPARG—stomach cancer	3.6e-06	4e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—CDKN1B—stomach cancer	3.56e-06	3.95e-05	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—NOS3—stomach cancer	3.55e-06	3.95e-05	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism—PTGS2—stomach cancer	3.54e-06	3.94e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—MTHFR—stomach cancer	3.54e-06	3.94e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—MAPK8—stomach cancer	3.54e-06	3.93e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling by GPCR—IL6—stomach cancer	3.46e-06	3.85e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—PPP2R1A—stomach cancer	3.43e-06	3.82e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—CCND1—stomach cancer	3.39e-06	3.77e-05	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—PPARG—stomach cancer	3.39e-06	3.77e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—JUN—stomach cancer	3.38e-06	3.76e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—GSTP1—stomach cancer	3.37e-06	3.74e-05	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—PPARG—stomach cancer	3.36e-06	3.74e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—HMOX1—stomach cancer	3.32e-06	3.69e-05	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—ALB—stomach cancer	3.31e-06	3.69e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—MMP9—stomach cancer	3.29e-06	3.66e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—CDKN1A—stomach cancer	3.28e-06	3.65e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—CAV1—stomach cancer	3.27e-06	3.63e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—VEGFA—stomach cancer	3.27e-06	3.63e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—APOA1—stomach cancer	3.26e-06	3.62e-05	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—PTGS2—stomach cancer	3.25e-06	3.61e-05	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—ALB—stomach cancer	3.24e-06	3.6e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—STAT3—stomach cancer	3.23e-06	3.6e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—MAPK8—stomach cancer	3.2e-06	3.56e-05	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—NOS3—stomach cancer	3.17e-06	3.53e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—TYMS—stomach cancer	3.13e-06	3.48e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	3.12e-06	3.47e-05	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—NOS3—stomach cancer	3.09e-06	3.44e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—GSTM1—stomach cancer	3.09e-06	3.44e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—MAPK3—stomach cancer	3.09e-06	3.44e-05	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—ALB—stomach cancer	3.05e-06	3.39e-05	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—ALB—stomach cancer	3.02e-06	3.36e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—MYC—stomach cancer	3.01e-06	3.34e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—VEGFA—stomach cancer	2.96e-06	3.29e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—MAPK1—stomach cancer	2.94e-06	3.27e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—EGFR—stomach cancer	2.94e-06	3.27e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—STAT3—stomach cancer	2.93e-06	3.26e-05	CbGpPWpGaD
Azelastine—CYP2A6—Metabolism—PIK3CA—stomach cancer	2.93e-06	3.25e-05	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—NOS3—stomach cancer	2.92e-06	3.24e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—ERCC2—stomach cancer	2.91e-06	3.23e-05	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—PTGS2—stomach cancer	2.9e-06	3.22e-05	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—NOS3—stomach cancer	2.89e-06	3.21e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—PPARG—stomach cancer	2.87e-06	3.19e-05	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—PTGS2—stomach cancer	2.83e-06	3.15e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—MAPK3—stomach cancer	2.8e-06	3.11e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—KRAS—stomach cancer	2.78e-06	3.09e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—MTHFR—stomach cancer	2.73e-06	3.04e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—MYC—stomach cancer	2.72e-06	3.03e-05	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—PTGS2—stomach cancer	2.67e-06	2.97e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—MAPK1—stomach cancer	2.66e-06	2.96e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—EGFR—stomach cancer	2.66e-06	2.96e-05	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—PTGS2—stomach cancer	2.64e-06	2.94e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—ALB—stomach cancer	2.58e-06	2.87e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—PIK3CA—stomach cancer	2.55e-06	2.84e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—CAV1—stomach cancer	2.52e-06	2.8e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—APOA1—stomach cancer	2.52e-06	2.8e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—KRAS—stomach cancer	2.51e-06	2.8e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—NOS3—stomach cancer	2.47e-06	2.75e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—TP53—stomach cancer	2.47e-06	2.74e-05	CbGpPWpGaD
Azelastine—CYP2B6—Metabolism—PIK3CA—stomach cancer	2.36e-06	2.63e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—HRAS—stomach cancer	2.36e-06	2.62e-05	CbGpPWpGaD
Azelastine—CYP2E1—Metabolism—PIK3CA—stomach cancer	2.31e-06	2.57e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—PIK3CA—stomach cancer	2.31e-06	2.57e-05	CbGpPWpGaD
Azelastine—CYP3A5—Metabolism—PIK3CA—stomach cancer	2.31e-06	2.57e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—PTGS2—stomach cancer	2.26e-06	2.51e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—IL6—stomach cancer	2.26e-06	2.51e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—TP53—stomach cancer	2.23e-06	2.48e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—PPARG—stomach cancer	2.22e-06	2.47e-05	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism—PIK3CA—stomach cancer	2.18e-06	2.42e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—HRAS—stomach cancer	2.14e-06	2.38e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—IL6—stomach cancer	2.05e-06	2.27e-05	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—PIK3CA—stomach cancer	2e-06	2.22e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—ALB—stomach cancer	1.99e-06	2.22e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—NOS3—stomach cancer	1.91e-06	2.12e-05	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—PIK3CA—stomach cancer	1.78e-06	1.98e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—PTGS2—stomach cancer	1.74e-06	1.94e-05	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—PIK3CA—stomach cancer	1.74e-06	1.94e-05	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—PIK3CA—stomach cancer	1.64e-06	1.82e-05	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—PIK3CA—stomach cancer	1.63e-06	1.81e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—PIK3CA—stomach cancer	1.39e-06	1.55e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—PIK3CA—stomach cancer	1.07e-06	1.19e-05	CbGpPWpGaD
